Insulet and Ypsomed Sign Distribution Agreement for Europe: Ypsomed Expected to Expand Market for Insulin Pump Therapy

Document Sample
Insulet and Ypsomed Sign Distribution Agreement for Europe: Ypsomed Expected to Expand Market for Insulin Pump Therapy Powered By Docstoc
					Insulet and Ypsomed Sign
Distribution Agreement for Europe:
Ypsomed Expected to Expand
Market for Insulin Pump Therapy
                                                                                Reference Code: GDME0013M&A
                                                                                Publication Date: JAN 2010




Medical Equipment Deal Analysis                                               GDME0013M&A / Published JAN 2010

© GlobalData. This brief is a licensed product and is not to be photocopied                                  Page 1
Source: www.medicaletrack.com
Table of Contents


1           Table of Contents

1      Table of Contents.........................................................................................................2

1.1       List of Tables....................................................................................................................................................... 3

1.2       List of Figures..................................................................................................................................................... 3


2 Insulet and Ypsomed Sign Distribution Agreement for Europe: Ypsomed
Expected to Expand Market for Insulin Pump Therapy ..................................................4

2.1       Overview .............................................................................................................................................................. 4

2.2       Deal Details.......................................................................................................................................................... 4

2.3       Background ......................................................................................................................................................... 5

2.4    Key Trends Analyzed in the Deal................................................................................................................... 6
  2.4.1    Success in the US........................................................................................................................................ 6
  2.4.2    Outcome of the Agreemen
				
DOCUMENT INFO
Shared By:
Stats:
views:34
posted:7/19/2010
language:English
pages:13
Description: Insulet and Ypsomed Sign Distribution Agreement for Europe: Ypsomed Expected to Expand Market for Insulin Pump Therapy Summary Insulet is a start up company in the insulin delivery market. The company’s product, the Omnipod, which is a disposable insulin pump was approved by the USFDA in January. The company began marketing its product in October 2005. The initial focus of the company was in the Eastern United States and then progressed towards marketing in the entire country. The company received a CE mark for Omnipod in 2009 and this distribution agreement with Ypsomed is to increase its sales and marketing efforts in countries outside the US. GlobalData’s analysts mapped a strong deal rationale for this distribution agreement. Insulet, though it had an innovative product, did not make a very huge impact as expected by industry analysts in the US. This was primarily due to its lack of strong distribution network in the diabetes care market in the US. Insulet, in signing an agreement with Ypsomed (which has one of the strongest distribution network for the insulin pump market in Europe) has made a well strategised decision that would help the company expand its market and also gain market share. Scope - Details of the agreement included. - Rationale behind the deal. - Key trends prevalent in the medical equipment market derived from the deal. - Forecast market revenue for the global traditional and disposable insulin pumps market. Reasons to buy - Identify key distribution trends in the medical equipment market. - Track competitor product portfolios and distribution agreements. - Assess future outlook of the companies in question.
BUY THIS DOCUMENT NOW PRICE: $500 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.